MIRA INFORM REPORT

 

 

Report Date :

17.11.2012

 

IDENTIFICATION DETAILS

 

Name :

EMBIO LIMITED

 

 

Formerly Known As :

EMMELLEN BIOTECH PHARMACEUTICALS LIMITED (w.e.f.17.07.2009)

 

 

Registered Office :

501, Sentinal, Central Avenue Road, Hiranandani Gardens, Powai, Mumbai – 400067, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

20.01.1986

 

 

Com. Reg. No.:

11-038680

 

 

Capital Investment / Paid-up Capital :

Rs. 91.351 Millions

 

 

CIN No.:

[Company Identification No.]

U24110MH1986PLC038680

 

 

PAN No.:

[Permanent Account No.]

AAACE1154C

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Ephedrine and Pseudoephedrine salts.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 2800000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

 

 

Source : CIA

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term Bank facilities : BBB+

Rating Explanation

Moderate degree of safety. It carry moderate credit risk.

Date

January 2012

 

 

Rating Agency Name

CARE

Rating

Short term Bank facilities : A3+

Rating Explanation

Moderate degree of safety. It carry higher credit risk.

Date

January 2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

501, Sentinal, Central Avenue Road, Hiranandani Gardens, Powai, Mumbai – 400067, Maharashtra, India

Tel. No.:

91-22-66797200

Fax No.:

91-22-66797222

E-Mail :

chirag@embio.co.in

embio@embio.co.in

sales@embio.co.in

Website :

http://www.embio.co.in

 

 

Factory :

E - 21-22, MIDC Industrial Estate, Mahad - 402309,  District Raigad, Maharashtra, India

Tel. No.:

91-2145-232059 / 060 / 061

Fax No.:

91-2145-232375

E-Mail :

mahad@embio.co.in

 

 

DIRECTORS

 

AS ON 03.08.2012

 

Name :

Mr. Devesh Malladi

Designation :

Managing director

Address :

1301, Solitaire, Hiranandani Gardens, Powai, Mumbai – 400076, Maharashtra, India

Date of Birth/Age :

13.07.1966

Qualification :

M. Tech

Date of Appointment :

20.04.2009

PAN No.:

AAAPD6878R

DIN No.:

00025221

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24110MH1986PLC038680

EMBIO LIMITED

Managing director

20/04/2009

19/09/1997

Active

NO

2

U74140MH1998PTC114311

URAV CONSULTANCY PRIVATE LIMITED

Director

24/11/1998

24/11/1998

Amalgamated

NO

3

U65993MH1997PTC111641

GURU NARAYAN FINCAP PRIVATE LIMITED

Director

24/11/1998

24/11/1998

Amalgamated

NO

4

U99999MH1988PTC136042

MALLADI INVESTMENTS PRIVATE LIMITED

Director

26/12/1998

26/12/1998

Amalgamated

NO

5

U51900MH1998PTC116955

HAKUNA FARMA PRIVATE LIMITED

Director

05/07/1999

05/07/1999

Amalgamated

NO

6

U24230MH1991PTC063919

PRERNA PHARMA INDUSTRIES PRIVATE LIMITED

Director

11/01/2002

11/01/2002

Active

NO

7

U24230MH2004PTC144351

MALLADI INDUSTRIES PRIVATE LIMITED

Director

04/02/2004

04/02/2004

Active

NO

8

U24230MH2005PLC154829

INJEN RX PHARMA LIMITED

Director

15/07/2005

15/07/2005

Under liquidation

NO

9

U72900MH2009PTC189521

RIK TECHNOLOGIES INDIA PRIVATE LIMITED

Director

12/01/2009

12/01/2009

Active

NO

 

 

Name :

Mr. Rajendra Kamalakant Prabhu

Designation :

Whole-time director

Address :

5/81, Juhu Tarang CHS, New D.N. Nagar, Andheri (West), Mumbai – 400053, Maharashtra, India

Date of Birth/Age :

09.05.1961

Qualification :

Chartered Accountant, LLB, B.Com

Date of Appointment :

22.09.2008

PAN No.:

AAAPD6878R

DIN No.:

00025412

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH2005PLC154829

INJEN RX PHARMA LIMITED

Director

15/07/2006

15/07/2006

-

Under liquidation

NO

2

U24110MH1986PLC038680

EMBIO LIMITED

Whole-time director

22/09/2008

26/08/2008

-

Active

NO

3

U24230MH2004PTC144351

MALLADI INDUSTRIES PRIVATE LIMITED

Director

28/09/2010

05/03/2010

22/04/2011

Active

NO

 

 

Name :

Mr. Hanumantha Avadhani Malladi

Designation :

Director

Address :

1-35/4, Malladi Vari Street, Nazerpet, Tenali, Guntur – 522201, Andhra Pradesh, India

Date of Birth/Age :

18.08.1934

Qualification :

M. Sc (Chem)

Date of Appointment :

05.06.1990

PAN No.:

AAAPA6776B

DIN No.:

00055989

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24110MH1986PLC038680

EMBIO LIMITED

Director

05/06/1990

05/06/1990

-

Active

NO

2

L24294TN1986PLC013087

MANALI PETROCHEMICALS LIMITED

Director

15/12/1990

15/12/1990

17/04/2008

Active

NO

3

U99999MH1988PTC136042

MALLADI INVESTMENTS PRIVATE LIMITED

Director

26/12/1998

26/12/1998

22/04/2011

Amalgamated

NO

4

U24111MH1991PLC183170

KARNATAKA MALLADI BIOTICS LIMITED

Director

26/03/2003

26/03/2003

-

Amalgamated

NO

5

U24230MH2004PTC144351

MALLADI INDUSTRIES PRIVATE LIMITED

Director

04/02/2004

04/02/2004

22/04/2011

Active

NO

6

U01119AP2005PTC046334

MALLADI AGRO INDUSTRIES PRIVATE LIMITED

Director

25/05/2005

25/05/2005

-

Active

NO

7

U65993TN1994PLC026971

SOMAYAJULU AND COMPANY LIMITED

Director

03/12/2010

03/12/2010

22/05/2012

Active

NO

 

 

Name :

Mr. Jayant Narayan Godbole

Designation :

Director

Address :

604-A, Cottage Land Co-operative Housing Society, Plot No. 16A, Sector-19, Navi Mumbai – 400706, Maharashtra, India

Date of Birth/Age :

17.02.1945

Qualification :

B. Tech (IIT Bombay) MBA (JBIML)

Date of Appointment :

21.10.2005

DIN No.:

00056830

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74999MH2003PTC139774

INVENT ASSETS SECURITISATION AND RECONSTRUCTION PRIVATE LIMITED

Director

26/05/2005

26/05/2005

11/07/2008

Active

NO

2

U67190MH2005PTC155404

INVENT ARC PRIVATE LIMITED

Director

17/08/2005

17/08/2005

11/07/2008

Active

NO

3

U24110MH1986PLC038680

EMBIO LIMITED

Director

21/10/2005

21/10/2005

-

Active

NO

4

L28120MH1992PLC069252

TECHNOCRAFT INDUSTRIES (INDIA) LIMITED

Director

01/03/2006

01/03/2006

18/05/2009

Active

NO

5

L17229UP1994PLC017199

J. K. CEMENT LIMITED

Director

25/08/2007

29/07/2006

-

Active

NO

6

L51909WB1935PLC008194

GILLANDERS ARBUTHNOT AND COMPANY LIMITED

Director

05/09/2007

07/03/2007

-

Active

NO

7

L31300DN1961PLC000232

IMP POWERS LIMITED

Director

05/12/2008

16/03/2007

-

Active

NO

8

L21019WB1981PLC034161

EMAMI PAPER MILLS LIMITED

Director

17/03/2007

17/03/2007

-

Active

NO

9

L72200MH2000PLC130073

MW UNITEXX LIMITED

Director

27/09/2007

16/04/2007

23/04/2010

Active

NO

10

L15432UP1932PLC025186

THE OUDH SUGAR MILLS LIMITED

Director

17/12/2007

23/04/2007

-

Active

NO

11

L21012CT1980PLC001682

MADHYA BHARAT PAPERS LIMITED

Director

25/07/2007

25/07/2007

-

Active

NO

12

L51420MH1989PLC053772

BILPOWER LIMITED

Director

22/09/2007

26/07/2007

17/06/2008

Active

NO

13

L65921GA1967PLC000157

ZUARI GLOBAL LIMITED

Director

24/09/2007

01/08/2007

-

Active

NO

14

U26951UP1988PLC010111

JAYKAYCEM LIMITED

Director

26/07/2008

09/02/2008

-

Amalgamated

NO

15

L26941GJ1956PLC000840

SAURASHTRA CEMENT LIMITED

Director

27/06/2012

28/04/2008

-

Active

NO

16

L24110GJ1973PLC002247

GUJARAT ALKALIES AND CHEMICALS LIMITED

Director

04/03/2009

04/03/2009

-

Active

NO

17

L45203MH2008PLC178061

KESAR TERMINALS AND INFRASTRUCTURE LIMITED

Director

14/09/2010

29/01/2010

-

Active

NO

18

U65999WB2010PTC141896

MIDAS ASSET RECONSTRUCTION COMPANY PRIVATE LIMITED

Director

24/05/2011

11/08/2010

07/11/2012

Active

NO

19

U65100MH2010PLC199319

IDBI ASSET MANAGEMENT LIMITED

Director

28/06/2012

09/11/2010

-

Active

NO

20

U65910GA2009PLC006177

ZUARI AGRO CHEMICALS LIMITED

Director

07/08/2012

20/05/2011

-

Active

NO

21

U74120MH2011PLC222597

KESAR MULTIMODAL LOGISTICS LIMITED

Director

30/09/2011

30/09/2011

-

Active

NO

 

 

Name :

Mr. Ajit Tekchand Vaswani

Designation :

Director

Address :

502, Solitaire, Hiranandani Gardens, Powai, Mumbai – 400076, Maharashtra, India

Date of Birth/Age :

05.07.1937

Qualification :

Chartered Accountant, Company Secretary

Date of Appointment :

16.10.2001

DIN No.:

00057953

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24219KA1991PTC011795

PJ MARGO PRIVATE LIMITED

Director

16/12/1994

16/12/1994

-

Active

NO

2

L72200PN1963PLC012621

ZENSAR TECHNOLOGIES LIMITED

Director

09/02/1996

09/02/1996

-

Active

NO

3

U72200PN1984PLC034103

ZENSAR TRANSFORMATION SERVICES LIMITED

Director

15/03/2000

15/03/2000

-

Amalgamated

NO

4

L12801MH1963PLC012801

VULCAN ENGINEERS LIMITED

Director

03/10/2000

03/10/2000

16/02/2010

Active

NO

5

U24110MH1986PLC038680

EMBIO LIMITED

Director

16/10/2001

16/10/2001

-

Active

NO

6

U24119KA1994PTC016163

MARGO BIOCONTROLS PRIVATE LIMITED

Director

22/12/2003

22/12/2003

-

Active

NO

7

L45200MH2005PLC152061

KEC INTERNATIONAL LIMITED

Director

12/01/2006

12/01/2006

-

Active

NO

8

U15133PN2006PTC139152

SONOCO INDIA PRIVATE LIMITED

Director

08/05/2006

08/05/2006

-

Active

NO

9

U85100PN2011PTC141113

PRIME SURGICAL CENTERS PRIVATE LIMITED

Director

19/10/2011

19/10/2011

29/03/2012

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Chirag Arvind Vora

Designation :

Secretary

Address :

301/302 Paras Darshan, Modi Patel Road, Bhayander (West), Thane – 401101, Maharashtra, India

Date of Birth/Age :

19.10.1983

Date of Appointment :

01.11.2011

PAN No.:

AIJPV9105C

 

 

Name :

Mr. Sandeep Warang

Designation :

Company Secretary

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 03.08.2012

 

Names of Shareholders

 

No. of Shares

M Devesh (HUF)

 

1479014

Shobna Devesh Malladi

 

522014

Devesh Malladi

 

87015

Malladi Sundari jointly with Sarvani Malladi

 

174000

M. Srikant

 

87000

Malladi Samhith

 

30

Malladi Industries Private Limited, India

 

6786029

Total

 

9135102

 

 

AS ON 03.08.2012

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Bodies corporate

 

74.29

Directors or relatives of directors

 

9.52

Others

 

16.19

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Ephedrine and Pseudoephedrine salts.

 

 

Products :

ITC Code

Product Descriptions

293941

Ephedrine, Nor and Derivatives

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Axis Bank Limited, Trishul 3rd Floor, Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad – 380006, Gujarat, India

 

 

Facilities :

Secured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

Rupee term loans financial institutions secured

100.261

69.000

Working capital loans banks secured

146.919

97.304

Loans taken for vehicles secured

0.820

1.159

Total

248.000

167.463

 

 

Unsecured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

Loans directors unsecured

0.000

4.600

Deferred sales tax loan unsecured

2.964

3.147

Total

2.964

7.747

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

SSPA and Company

Chartered Accountants

Address :

1st Floor, Arjun Plot No. 6A, V P Road, Andheri-West, Mumbai – 400058, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

ABLFS2629F

 

 

Associates :

Ø       Prerna Pharma Industries Private Limited [U24230MH1991PTC063919]

Ø       Guru Narayan Fincap Private Limited [U65993MH1997PTC111641]

Ø       Malladi Investments Private Limited [U99999MH1988PTC136042]

Ø       Malladi Industries Private Limited [U24230MH2004PTC144351]

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

42,000,000

Equity Shares

Rs. 10/- each

Rs. 420.000 Millions

10,000,000

Preference Shares

Re. 1/- each

Rs. 10.000 Millions

 

Total

 

Rs. 430.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9,135,102

Equity Shares

Rs.10/- each

Rs. 91.351 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

91.351

91.351

98.347

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

613.014

580.383

529.114

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

704.365

671.734

627.461

LOAN FUNDS

 

 

 

1] Secured Loans

248.000

167.463

192.681

2] Unsecured Loans

2.964

7.747

7.801

TOTAL BORROWING

250.964

175.210

200.482

DEFERRED TAX LIABILITIES

148.747

118.056

89.444

 

 

 

 

TOTAL

1104.076

965.000

917.387

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

719.177

686.062

674.362

Capital work-in-progress

12.250

26.351

2.720

 

 

 

 

INVESTMENT

0.904

0.904

1.404

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

191.060

195.205

181.848

 

Sundry Debtors

185.393

122.640

135.878

 

Cash & Bank Balances

27.447

1.957

1.300

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

178.414

116.087

94.352

Total Current Assets

582.314

435.889

413.378

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

153.171

145.243

153.142

 

Other Current Liabilities

15.035

16.840

15.336

 

Provisions

42.363

22.123

5.999

Total Current Liabilities

210.569

184.206

174.477

Net Current Assets

371.745

251.683

238.901

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

1104.076

965.000

917.387

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

851.346

733.414

807.156

 

 

Other Income

35.735

36.247

19.949

 

 

TOTAL                                     (A)

887.081

769.661

827.105

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption materials changes inventories

352.599

304.594

 

 

 

Manufacturing service costs

126.158

84.300

 

 

 

Employee related expenses

79.267

76.983

 

 

 

Administrative selling other expenses

97.106

98.098

 

 

 

Research development expenditure

23.850

24.962

 

 

 

TOTAL                                     (B)

678.980

588.937

692.875

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

208.101

180.724

134.230

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

21.924

22.716

38.259

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

186.177

158.008

95.971

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

58.648

54.695

54.051

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

127.529

103.313

41.920

 

 

 

 

 

Less

TAX                                                                  (H)

62.941

30.139

13.515

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

64.588

73.174

28.405

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

51.174

49.905

27.508

 

 

 

 

 

Less/ Add

TAX ADJUSTMENT OF EARLIER YEAR

0.000

0.000

0.009

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

50.000

50.000

0.000

 

 

Dividend

31.957

21.905

5.999

 

BALANCE CARRIED TO THE B/S

33.805

51.174

49.905

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

F.O.B. Value of Exports

556.518

548.354

494.874

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

42.103

29.711

38.414

 

 

Capital Goods

7.531

0.000

0.000

 

TOTAL IMPORTS

49.634

29.711

38.414

 

 

 

 

 

 

Earnings Per Share (Rs.)

10.44

7.95

3.04

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

7.28

9.51

3.43

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

14.98

14.09

5.19

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

9.80

9.21

3.85

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.18

0.15

0.07

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.66

0.54

0.60

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.77

2.37

2.37

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

OPERATIONS

 

Sales for the year were Rs. 880.286 Millions as compared with Rs. 760.629 Millions of the previous year, an increase of 15.73 %. Profit before tax increased from Rs.103.313 Millions to Rs.127.529 Millions, an increase of 23.44%. This was largely the result of increased volumes and improved sales realizations.

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24110MH1986PLC038680

Name of the company

EMBIO LIMITED

Address of the registered office or of the principal place of  business in India of the company

501, Sentinal, Central Avenue Road, Hiranandani Gardens, Powai, Mumbai – 400067, Maharashtra, India

Email: prabhu@embio.co.in

This form is for

Modification of charge

Charge identification number of the modified 

80046613

Type of charge

Immovable Property

Book Debts

Movable Property

Others (Current Assets)

Particular of charge holder

Axis Bank Limited, Trishul 3rd Floor, Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad – 380006, Gujarat, India

CIN No.: L65110GJ1993PLC020769

Email: rajesh.laxman@axisbank.com

Nature of description of the instrument creating or modifying the charge

Supplemental Deed of Hypothecation dated 06.09.2012

Memorandum of Entry regarding creation of Mortgage by Depositing Title Deeds dated 06.09.2012

Date of instrument Creating the charge

06.09.2012

Amount secured by the charge

Rs. 150.000 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

CC=BR+4.00%, EPC/PCFC=BR+2.50% upto180 days and BR+3.75% period beyond 180 days and upto 270 days and BR+6% for overdue Bill, PSC/PSCFC=BR+2.50%, further refer agreement dt. 06.09.2012.

 

Terms of Repayment

On Demand

 

Margin

The DP will be calculated by applying the margin mention; For CC = Raw - material - 25.00%, Stock in Process - 30%, Finished Goods and Pkg Material - 25%, Book Debts (cover period 120 days) - 30%; for EPC = Export bill with title to goods duly endorsed in favour of Bank; for LC = Goods procured under LC; Bank Guarantee = -15%, -100% cash margin in case of disputed liabilities.

 

Extent and Operation of the charge

Pari passu first charge on entire current assets of the company and Pari passu Second charge on the Fixed Asset of the Company (excluding property of MMA) except vehicle, including Land and Building, Plant and Machinery situated at MIDC, Mahad, Maharashtra and Mandya, Karnataka for working capital facilities to the extent of Rs. 150.000 Millions as sanctioned by Axis Bank Limited

Short particulars of the property charged

Plot No. E-21, MIDC, Mahad, District – Raigad

 

Plot No. E-22/1, MIDC, Mahad, District – Raigad

 

RL-5, RL-6, RL-13 and RL-14 at Residential Zone of Mahad, District – Raigad

 

Plot No. 70 (Part), 71, 72, 73 and 74 situated at Tubinkere Industrial Area, Yliyur Village, Kothani Hubli, Mandya District, Karnataka

 

Flat No. 9, 10, 11 and 12 in the building known as Arun Nagar, Village Nandgaon, Tarf Birwadi, Taluka Mahad, District – Raigad

 

Charge has created on all the moveable goods & fixed assets both present and future, all stock of raw materials, work in progress, semi finished goods described as movable properties.

 

Charge has created on all the present and future book debts

Date of latest modification prior to the present modification

31.10.2011

Particulars of the present modification 

Enhancement of working capital limit from 125.000 Millions to 150.000 Millions

 

 

CONTINGENT LIABILITIES:

(Rs. in millions)

Claims against the company not acknowledged as debts

31.03.2011

31.03.2010

Disputed amount of Income Tax

Nil

8.813

Suits filed by ex-employees

2.257

3.345

 

 

FIXED ASSETS

 

Ø       Land

Ø       Buildings

Ø       Plant and machinery

Ø       Furniture and fixture

Ø       Office equipment

Ø       Vehicle

Ø       Technical knowhow


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 54.99

UK Pound

1

Rs. 87.21

Euro

1

Rs. 70.22

 

 

INFORMATION DETAILS

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.